As an indicator to observe cardiac dynamics during the early stages of heart diseases (e.g., myocardial infarction), PLCL/Mo composites could provide information on heart rate and can be further utilized to predict myocardial strain/stiffness when integrated with an appropriate encapsulation strategy (Supplementary Fig. 31). This evidence concerns the gene PLCL1 and heart disorder.